Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

MAQC and the era of genomic medicine

The MicroArray Quality Control consortium—a 16-year international effort led by the FDA and involving hundreds of scientists from academia, industry and government—helped make genomic medicine a reality.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: The four project phases of the MAQC consortium (top) and advances in related genomic regulatory science (bottom).


  1. Tan, P. K. et al. Nucleic Acids Res. 31, 5676–5684 (2003).

    Article  CAS  Google Scholar 

  2. Taylor, J. K. Anal. Chem. 55, 600A–608A (1983).

    Article  CAS  Google Scholar 

  3. Zook, J. M. et al. Nat. Biotechnol. 37, 561–566 (2019).

    Article  CAS  Google Scholar 

  4. Critical Path Institute. Patient-Reported Outcome Consortium (accessed 1 August 2021).

  5. Quantitative Imaging Biomarkers Alliance. (accessed 2 August 2021).

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Marc Salit.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Salit, M., Woodcock, J. MAQC and the era of genomic medicine. Nat Biotechnol 39, 1066–1067 (2021).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing